{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T02:57:38Z","timestamp":1717815458607},"reference-count":22,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Hosp. Clin."],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p>This is a double-blind, placebo-controlled study of the efficacy, safety, and tolerability of sibutramine in the management of obese patients for a 6-month period. METHOD: Sixty-one obese patients (BMI &gt;30, &lt;40 kg\/m2), aged 18-65 years were evaluated. In the first phase of the study (30 days), the patients were given a placebo. We monitored compliance with a low-calorie diet (1200 kcal\/day) and to the placebo. In the next stage, the double-blind phase (6 months), we compared placebo and sibutramine (10 mg\/day). The criteria for evaluating efficacy were weight loss, reduction in body mass index (BMI), and abdominal and hip circumferences. Tolerability was assessed based on reported side effects, variation in arterial blood pressure and heart rate, metabolic profile (fasting glucose, total cholesterol and its fractions, and triglycerides), laboratory tests (renal and hepatic functions), and flow Doppler echocardiogram. RESULTS: We observed a greater weight loss (7.3 kg, 8% vs 2.6 kg, 2.8%) and a reduction in body mass index (7.4% vs 2.1%) in the sibutramine group than in the placebo group. Classifying the patients into 4 subgroups according to weight loss (weight gain, loss &lt;5%, loss of 5% to 9.9%, and loss &gt;10%), we observed a weight loss of &gt;5% in 40% of the patients on sibutramine compared with 12.9% in the placebo group. We also detected weight gain in 45.2% of the placebo group compared to 20% in the sibutramine group. The sibutramine group showed improvement in HDL- cholesterol values (increased by 17%) and triglyceride values (decreased by 12.8%). This group also showed an increase in systolic blood pressure (6.7%, 5 mmHg). There were no changes in echocardiograms comparing the beginning and end of follow-up, and side effects did not lead to discontinuation of treatment. DISCUSSION: Sibutramine proved to be effective for weight loss providing an 8% loss of the initial weight. Compliance to prolonged treatment was good, and side effects did not result in discontinuation of treatment. These data confirmed the good efficacy, tolerability, and safety profiles of sibutramine for treatment of obesity.<\/jats:p>","DOI":"10.1590\/s0041-87812002000300003","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T13:22:18Z","timestamp":1114608138000},"page":"98-102","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of efficacy, reliability, and tolerability of sibutramine in obese patients, with an echocardiographic study"],"prefix":"10.1590","volume":"57","author":[{"given":"Alfredo","family":"Halpern","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Cozer","family":"Leite","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Herszkowicz","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Barbato","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Arruda","family":"Costa","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","first-page":"577","article-title":"The epidemiology of obesity","volume":"8","author":"HODGE AM","year":"1994","journal-title":"Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0300-595X","issn-type":"print"},{"key":"ref2","series-title":"Progress in obesity research","first-page":"661","volume-title":"The worldwide epidemic of obesity","author":"SEIDELL JC","year":"1999","edition":"8"},{"key":"ref3","year":"1997"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/jcem-54-2-254","article-title":"Relation of body fat distribution to metabolic complications of obesity","volume":"54","author":"KISSEBACH AH","year":"1982","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref5","first-page":"1261","article-title":"Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden","volume":"289","author":"LAPIDUS L","year":"1984","journal-title":"Br Med J","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1447","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"HUBERT H B","year":"1983","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.288.6428.1401","article-title":"Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 -year follow-up participants in the study of men born in 1913","volume":"288","author":"LARSSON B","year":"1984","journal-title":"Br Med J","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1447","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S0004-27302000000100013","article-title":"Apn\u00e9ia do sono em obesos","volume":"4(1)","author":"MANCINI M C","year":"2000","journal-title":"Arq Bras Metab"},{"key":"ref9","series-title":"Obesidade","first-page":"191","author":"HALPERN A","year":"1998"},{"key":"ref10","first-page":"397","article-title":"Beneficial health effects of modest weight loss","volume":"16","author":"GOLDSTEIN DJ","year":"1992","journal-title":"Int J Obes Relat Met Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/jama.1996.03540230057036","article-title":"Long term pharmacotherapy in the management of obesity","volume":"276","year":"1996","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref12","year":"1997"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction","volume":"23","author":"HANSEN DL","year":"1999","journal-title":"Int J Obesity"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss","volume":"7","author":"BRAY GA","year":"1999","journal-title":"Obesity Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomized trial","volume":"356","author":"JAMES WPT","year":"2000","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.88.5.2460","article-title":"Human blood pressure determination by sphygmomanometry","volume":"88","author":"PERLOFF D","year":"1993","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref17","series-title":"Anthropometric Standardization Reference Manual","author":"LOHMAN TG","year":"1998"},{"key":"ref18","series-title":"Statistical methods in medical research","first-page":"282","author":"ARMITAGE P","year":"1987","edition":"2"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1378\/chest.90.2.275","article-title":"Cardiovascular adaptation to obesity and hypertension","volume":"90","author":"LAVIE CJ","year":"1986","journal-title":"Chest","ISSN":"http:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9149(94)90347-6","article-title":"Left ventricular filling in young normotensive obese adults","volume":"73","author":"KU C S","year":"1994","journal-title":"Am J Cardiol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine - phentermine","volume":"337","author":"CONNOLLY H M","year":"1997","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/j.1550-8528.1999.tb00419.x","article-title":"Absence of cardiac valve dysfunction in obese patients treated with sibutramine","volume":"7","author":"BACH DS","year":"1999","journal-title":"Obes Res","ISSN":"http:\/\/id.crossref.org\/issn\/1071-7323","issn-type":"print"}],"container-title":["Revista do Hospital das Cl\u00ednicas"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rhc\/v57n3\/a03v57n3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T21:40:21Z","timestamp":1495662021000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0041-87812002000300003&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0041-87812002000300003"],"URL":"https:\/\/doi.org\/10.1590\/s0041-87812002000300003","relation":{},"ISSN":["0041-8781"],"issn-type":[{"value":"0041-8781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}